Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
PA

Patrick René Angibaud — 101 Patents

Johnson & Johnson: 79 patents #47 of 7,810Top 1%
ALAstex Therapeutics Limited: 19 patents #10 of 199Top 6%
Louviers, FR: #1 of 61 inventorsTop 2%
Overall (All Time): #14,231 of 4,157,543Top 1%
101 Patents All Time
Patrick René Angibaud has been granted 101 US patents while listed as an inventor at Johnson & Johnson. The first was granted in 1999 and the most recent in September 2024. Patrick René Angibaud ranks #14,231 of 4,157,543 US inventors in our database (top 0.34%). Patent records list Patrick René Angibaud in Louviers, FR.

Issued Patents All Time

Showing 1–25 of 101 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12084462 Spiro bicyclic inhibitors of menin-MLL interaction Vineet Pande, Barbara Herkert, Daniel Jason Krosky, Olivier Alexis Georges Querolle, Aaron Nathaniel Patrick +1 more 2024-09-10 $185,485,000
11542247 Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment of cancer Diego Broggini, Filip Albert C Cuyckens, Steven Anna Hostyn, Russell Mark Jones, Olivier Alexis Georges Querolle +1 more 2023-01-03 $346,989,000
11530226 Azepane inhibitors of menin-MLL interaction Vineet Pande, Barbara Herkert, Daniel Jason Krosky, Olivier Alexis Georges Querolle, Aaron Nathaniel Patrick +1 more 2022-12-20 $538,765,000
11396517 Exo-aza spiro inhibitors of menin-MLL interaction Xuedong Dai, Olivier Alexis Georges Querolle, Daniel Jason Krosky, Wei CAI, Liqiang FU +8 more 2022-07-26 $1,169,316,000
11267804 (R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity Olivier Alexis Georges Querolle, Didier Jean-Claude Berthelot, Christophe Meyer, Matthieu WILLOT, Lieven Meerpoel +1 more 2022-03-08 $372,209,000
11220517 Spiro bicyclic inhibitors of menin-MLL interaction Vineet Pande, Barbara Herkert, Daniel Jason Krosky, Olivier Alexis Georges Querolle, Aaron Nathaniel Patrick +1 more 2022-01-11 $249,880,000
11155555 Compounds Diego Broggini, Helene France Solange Colombel, Filip Albert C Cuyckens, Steven Anna Hostyn, Russell Mark Jones +2 more 2021-10-26 $230,543,000
11130751 Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors Olivier Alexis Georges Querolle, Didier Jean-Claude Berthelot, Christophe Meyer, Matthieu WILLOT, Lieven Meerpoel +1 more 2021-09-28 $293,549,000
10975100 Fused bicyclic inhibitors of menin-MLL interaction Vineet Pande, Barbara Herkert, Daniel Jason Krosky, Olivier Alexis Georges Querolle, Aaron Nathaniel Patrick 2021-04-13 $63,321,000
10894793 Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors Didier Jean-Claude Berthelot, Laurence Anne Mevellec, Sophie Coupa, Christophe Gabriel Marcel Demestre, Lieven Meerpoel +6 more 2021-01-19 $146,074,000
10745409 Azepane inhibitors of menin-MLL interaction Vineet Pande, Barbara Herkert, Daniel Jason Krosky, Olivier Alexis Georges Querolle, Aaron Nathaniel Patrick +1 more 2020-08-18 $101,666,000
10611778 Fused bicyclic inhibitors of menin-MLL interaction Vineet Pande, Barbara Herkert, Daniel Jason Krosky, Olivier Alexis Georges Querolle, Aaron Nathaniel Patrick 2020-04-07 $165,837,000
10526316 Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors Olivier Alexis Georges Querolle, Didier Jean-Claude Berthelot, Christophe Meyer, Matthieu WILLOT, Lieven Meerpoel +1 more 2020-01-07 $77,223,000
10519137 Pyrazolyl quinoxaline kinase inhibitors Gordon Saxty, Christopher William Murray, Valerio Berdini, Gilbert Ebai Besong, Steven John Woodhead +12 more 2019-12-31
10272087 Pteridines as FGFR inhibitors Gordon Saxty, Christopher Charles Frederick Hamlett, Valerio Berdini, Christopher William Murray, Olivier Alexis Georges Querolle +1 more 2019-04-30
10202387 Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors Laurence Anne Mevellec, Lieven Meerpoel, Sophie Coupa, Virginie Sophie Poncelet, Isabelle Noëlle Constance Pilatte +6 more 2019-02-12 $117,769,000
10087187 Imidazopyridazine derivatives as PI3KB inhibitors Laurence Anne Mevellec, Lieven Meerpoel, Sophie Coupa, Virginie Sophie Poncelet, Isabelle Noëlle Constance Pilatte +6 more 2018-10-02 $95,730,000
10045982 Substituted pyrido[2,3-b]pyrazines as FGFR kinase inhibitors Valerio Berdini, Gordon Saxty, Olivier Alexis Georges Querolle, Virginie Sophie Poncelet, Bruno Roux +1 more 2018-08-14
10039759 Quinolines as FGFR kinase modulators Valerio Berdini, Steven John Woodhead, Gordon Saxty 2018-08-07
9856236 Substituted quinoxalines as FGFR kinase inhibitors Gordon Saxty, Christopher William Murray, Valerio Berdini, Gilbert Ebai Besong, Christopher Charles Frederick Hamlett +2 more 2018-01-02
9850228 Pyrazolyl quinoxaline kinase inhibitors Gordon Saxty, Christopher William Murray, Valerio Berdini, Gilbert Ebai Besong, Christopher Charles Frederick Hamlett +20 more 2017-12-26
9757364 Naphthyridine derivative compounds Michel Obringer, Julien Marin, Matthieu Jeanty 2017-09-12
9737544 Compounds Isabelle Noëlle Constance Pilatte, Olivier Alexis Georges Querolle 2017-08-22
9636341 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase Marc Gustaaf Celine Verdonck, Bruno Roux, Isabelle Noëlle Constance Pilatte, Peter Ten Holte, Janine Arts +1 more 2017-05-02 $67,428,000
9598396 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors Laurence Anne Mevellec, Bruno Roux, Pierre-Henri Storck, Christophe Meyer, Jorge Eduardo Vialard 2017-03-21 $98,944,000